Dogwood Therapeutics Inc (DWTX) — Institutional Holders Breakdown (Q2 2026)

DWTX ranks #8808 out of 37701 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

DWTX is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

17 institutions disclose a position in DWTX, but none treat it as a major bet — even Armistice Capital, LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Activest Wealth Management has trimmed its DWTX position for two straight quarters, cutting it by $91.0 while still holding $162.0.

DWTX reported a net loss of $34.3M in its latest fiscal year.

• Not yet profitable — net loss of $34.3M in the latest fiscal year
• Net income declined year over year, from -$12.3M to -$34.3M
• Operating cash flow was negative, using $15.6M in cash
• Current ratio of 2.76x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.20x equity — within a conventional range